At 3:00 p.m., Friday, February 4, 2022
Hirosaki LI held a joint press conference on the marketing authorization of the human (autologous) oral mucosa-derived epithelial cell sheet using human amniotic membrane substrate (brand name: Sakracy) with Kyoto Prefectural University of Medicine, National Center for Geriatrics and Gerontology, and Foundation for Biomedical Research and Innovation at Kobe.